Ptosis during hematologic malignancy in children

Ekici A., Yakut A., BÖR Ö., Yimenicioglu S., ÇARMAN K. B., ŞAYLISOY S.

PEDIATRICS INTERNATIONAL, vol.56, no.2, pp.264-266, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 56 Issue: 2
  • Publication Date: 2014
  • Doi Number: 10.1111/ped.12238
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.264-266
  • Eskisehir Osmangazi University Affiliated: Yes


Neurological symptoms such as ptosis may develop due to either chemotherapeutic agents or involvement of the central nervous system (CNS) during hematologic malignancy. It is difficult to make this distinction according to clinical symptoms and magnetic resonance imaging findings. If the neurologic symptoms are increased, it is a warning of CNS involvement. Herein are described the clinical and neuroimaging features of three patients with hematologic malignancy who presented with ptosis.